Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of sitafloxacin for acute exacerbation of bronchiectasis in adults; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitafloxacin (sitafloxacin)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Acute Exacerbation of Bronchiectasis | Phase 4 | Status: UNKNOWN